Translation and Validation of Pelvic Girdle Questionnaire in Urdu Language

Urdu version of pelvic girdle questionnaire was drafted, tested for its reliability and validity on patients with pelvic girdle pain. Urdu version was linguistically acceptable and accurate for pregnant and post partum females with pelvic girdle pain. The result seems comparable to all the other versions and especially with original Norwegian version. This instrument is understandable and easy to find disability during pregnancy and post partum duration. It showed a good content, construct and convergent validity also present high internal consistency and test retest reliability.

Study Overview

• Status: Completed
• Conditions: Pelvic Girdle Pain
• Intervention / Treatment: Other: Straight leg raise

Detailed Description

The Pelvic Girdle Questionnaire is the only specific instrument designed to evaluate pain and activity limitations in pregnant or postpartum women with pelvic girdle pain. This study aimed to translate the Pelvic girdle questionnaire in Urdu language for Pakistani female patients and to verify the validation of the psychometric items of the Pelvic girdle questionnaire in population of Pakistan. The purpose of this study was to translate the Pelvic Girdle Questionnaire into Urdu and find out cross-culture validity and reliability of Urdu Pelvic girdle questionnaire among pregnant and postpartum females. A cultural adaptation and translation study was performing according to international guidelines. Study was conducted at different hospital settings. Pre test was conducted among 16 females during pregnancy & post-partum.

Key words: Disability Evaluation, Female, Urdu, Pelvic Girdle Pain and physiopathology, Pregnancy, Surveys and Questionnaires, Translation.

• Study Type: Observational
• Enrollment (Actual): 125

Contacts and Locations

Study Locations

• Pakistan
  • Punjab
    • Gujrat, Punjab, Pakistan, 50931
      • Faiza Kalsoom

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 50 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Female

• Sampling Method: Non-Probability Sample

Study Population

Female pregnant and post partum with pelvic girdle pain

Description

Inclusion Criteria:

• Age 18-50 years
• Only Females
• Able to read Urdu Language
• Pregnant women (gestational week 30-38)
• Postpartum women (given birth less than one year earlier)

Exclusion Criteria:

• Any neurological diseases (reflex changes & loss of sensation)
• Unstable medical conditions leading to fatigue
• Those that have prolapse or severe urinary disease
• Previous surgery on pelvis, lower limb or spine
• Cannot Understand Urdu
• Difficulty in understanding the Pelvic girdle questionnaire

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Content validity	Content validity score measured by content validity index. Assessment of 25 items by Clinician and native speaker experts rate all the items and all the value are above 0.70.Lower value was 0.92 and the highest value is 1 which is maximum value. Maximum score is given to 4, 5, 6,10,11,12,17,18,22 and 24 by experts (medical specialist and native speakers).	"through study completion, an average of 1 year"

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Internal consistency:	Cronbach's alpha was used for reliability. The reliability and internal consistency of PGQ for PGP patients Cronbach's alpha in week one and week two is 0.977 and 0.976 respectively. The value of α for activity subscale (1-20) is 0.986 and symptom subscale (21- 25) is 0.970.	"upto two weeks"

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Convergent validity	The value of Pearson correlation coefficient for Pelvic girdle questionnaire with Ostwestry disability index is 0.840 and NRS is 0.772.For the calculation of construct validity of PGQ we used Pearson's correlation coefficient with 5% significance. The correlation between week 1 and week 2 for each item of PGQ scale was ranging from 0.871-0.990. . We compared PGQ with ODI scale and Numeric rating pain scale. The construct validity of PGQ was measured by confidence interval 95% and level of significance at 5%.	"through study completion, an average of 1 year"
Test Retest reliability:	The tool reliability analyzes by ICC. The value of Intra class correlation for PGQ is 0.979 with 95 % of confidence interval.	"through study completion, an average of 1 year"

Collaborators and Investigators

• Sponsor: Riphah International University
• Investigators: Principal Investigator: sumera abdul hameed, Ms, Riphah International University

Publications and helpful links

General Publications

• Cong H, Liu H, Sun Y, Gao J, Liu J, Ma L, Stuge B, Chen L. Cross-cultural adaptation, reliability, and validity of a Chinese version of the pelvic girdle questionnaire. BMC Pregnancy Childbirth. 2021 Jun 30;21(1):470. doi: 10.1186/s12884-021-03962-8.
• Sakamoto A, Hoshi K, Gamada K. Transcultural Reliability and Validity of the Japanese-Language Version of the Pelvic Girdle Questionnaire. J Manipulative Physiol Ther. 2020 Jan;43(1):68-77. doi: 10.1016/j.jmpt.2018.11.019. Epub 2020 Feb 13.
• Acharya RS, Tveter AT, Grotle M, Khadgi B, Koju R, Eberhard-Gran M, Stuge B. Cross-Cultural Adaptation and Validation of the Nepali Version of the Pelvic Girdle Questionnaire. J Manipulative Physiol Ther. 2020 Mar-Apr;43(3):257-265. doi: 10.1016/j.jmpt.2019.04.009. Epub 2020 Jul 29.
• Munisamy A, Sahid, Sheerad Hussin, Muhammad. Content Validation and Content Validity Index Calculation of B40 Household's Financial Literacy. Turkish Online Journal of Qualitative Inquiry. 202112(8).
• Dunn G, Egger MJ, Shaw JM, Yang J, Bardsley T, Powers E, Nygaard IE. Trajectories of lower back, upper back, and pelvic girdle pain during pregnancy and early postpartum in primiparous women. Womens Health (Lond). 2019 Jan-Dec;15:1745506519842757. doi: 10.1177/1745506519842757.
• Gutke A, Stuge B, Elden H, Sandell C, Asplin G, Fagevik Olsen M. The Swedish version of the pelvic girdle questionnaire, cross-cultural adaptation and validation. Disabil Rehabil. 2020 Apr;42(7):1013-1020. doi: 10.1080/09638288.2018.1515991. Epub 2019 Feb 1.
• Rashidi Fakari F, Kariman N, Ozgoli G, Ghare Naz MS, Ghasemi V, Rashidi Fakari F, Ebadi A. Iranian version of Pelvic Girdle Questionnaire: Psychometric properties and cultural adaptation. J Res Med Sci. 2019 May 22;24:43. doi: 10.4103/jrms.JRMS_391_18. eCollection 2019.
• Fagundes FML, Cabral CMN. Cross-cultural adaptation of the Pelvic Girdle Questionnaire (PGQ) into Brazilian Portuguese and clinimetric testing of the PGQ and Roland Morris questionnaire in pregnancy pelvic pain. Braz J Phys Ther. 2019 Mar-Apr;23(2):132-139. doi: 10.1016/j.bjpt.2018.11.003. Epub 2018 Nov 17.
• Starzec M, Truszczynska-Baszak A, Stuge B, Tarnowski A, Rongies W. Cross-cultural Adaptation of the Pelvic Girdle Questionnaire for the Polish Population. J Manipulative Physiol Ther. 2018 Oct;41(8):698-703. doi: 10.1016/j.jmpt.2018.04.002. Epub 2018 Dec 26.
• Girard MP, O'Shaughnessy J, Doucet C, Lardon E, Stuge B, Ruchat SM, Descarreaux M. Validation of the French-Canadian Pelvic Girdle Questionnaire. J Manipulative Physiol Ther. 2018 Mar-Apr;41(3):234-241. doi: 10.1016/j.jmpt.2018.01.001. Epub 2018 Feb 15.

Study record dates

Study Major Dates

• Study Start (Actual): January 2, 2021
• Primary Completion (Actual): January 31, 2022
• Study Completion (Actual): January 31, 2022

Study Registration Dates

• First Submitted: October 21, 2022
• First Submitted That Met QC Criteria: February 20, 2023
• First Posted (Actual): March 2, 2023

Study Record Updates

• Last Update Posted (Actual): March 2, 2023
• Last Update Submitted That Met QC Criteria: February 20, 2023
• Last Verified: February 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Musculoskeletal Pain; Pelvic Pain; Pelvic Girdle Pain
• Other Study ID Numbers: Faiza Kalsoom

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No